Product image of Xeomin (Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins) supplied by GNH India

Xeomin

Active Ingredient:
Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins
Origin:
EU

Xeomin (Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins)

Xeomin is a purified botulinum toxin type A used to temporarily relax muscles. This neurotoxin-free complexing protein formulation is administered by healthcare professionals. Ideal for cosmetic and therapeutic muscle relaxation needs.

Manufacturer / TM Owner

Merz Pharmaceuticals Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xeomin is commonly used to reduce the appearance of fine lines and wrinkles by temporarily paralyzing underlying facial muscles. It is also used to treat medical conditions involving muscle overactivity, such as cervical dystonia or blepharospasm. Patients often ask, 'what is Xeomin used for' in both cosmetic and therapeutic contexts.

Side Effects

  • After administration, Xeomin works by blocking nerve signals to the muscles, leading to a gradual reduction in muscle activity. The effects typically appear within a few days and can last for several months. Most users notice a smoother appearance in treated areas as muscle contractions subside.

Precautions & Warnings

  • Xeomin should only be administered by a qualified healthcare professional experienced in its use. Patients with neuromuscular disorders or infections at the injection site should avoid treatment. Always inform your provider of your full medical history before receiving Xeomin injections.

Avoid Interactions

  • Xeomin may interact with medications that affect neuromuscular transmission, such as muscle relaxants or aminoglycoside antibiotics. Alcohol and other substances that may increase bleeding risk should be avoided around the time of treatment. Always discuss current medications with your healthcare provider before receiving Xeomin.

Frequently Asked Questions

Effects typically appear within 2–5 days, with full results visible in about 2 weeks.

Treatments are usually repeated every 3–4 months, depending on individual response.

Not suitable for pregnant or breastfeeding women or those with certain neuromuscular conditions.

Yes, it is FDA-approved for chronic migraines when administered by a healthcare professional.

Mild pain, redness, or swelling at the injection site are typical and temporary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clostridium Botulinum Neurotoxin Type A (150kd), Free Of Complexing Proteins

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT